Clinical Trials for Seneca Therapeutics

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Seneca Therapeutics

Clinical Trials (1)

SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET)

PHASE1Recruiting

36 participants

Started: May 19, 2025 · Completed: Jun 1, 2030

2 conditions2 sponsors1 location